Do you have to keep taking orelabrutinib once you start?

Whether orelabrutinib needs long-term administration depends on the comprehensive evaluation of disease progression, adverse reactions and physicians. It is not absolutely mandatory to continue the medication indefinitely. As a targeted drug, it is usually indicated for the management of specific hematologic malignancies. The treatment course must strictly follow the individualized treatment plan, and patients shall not discontinue the medication or adjust the dosage without authorization.